PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
20.22%
Similar revenue growth to CRWV's 23.55%. Walter Schloss would investigate if similar growth reflects similar quality.
49.27%
Cost growth above 1.5x CRWV's 19.16%. Michael Burry would check for structural cost disadvantages.
12.15%
Gross profit growth below 50% of CRWV's 25.15%. Michael Burry would check for structural issues.
-6.71%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
1.80%
R&D change of 1.80% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
-3.70%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
29.72%
Marketing expense growth less than half of CRWV's 248.84%. David Dodd would verify if efficiency advantage is sustainable.
1350.00%
Other expenses growth above 1.5x CRWV's 19.33%. Michael Burry would check for concerning trends.
13.47%
Operating expenses growth 50-75% of CRWV's 17.97%. Bruce Berkowitz would examine efficiency.
26.77%
Total costs growth 1.25-1.5x CRWV's 18.28%. Martin Whitman would scrutinize control.
1.06%
Similar interest expense growth to CRWV's 1.19%. Walter Schloss would investigate norms.
-6.61%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
10.90%
EBITDA growth below 50% of CRWV's 33.05%. Michael Burry would check for structural issues.
-8.46%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
10.98%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
-7.69%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
137.86%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
12.77%
Pre-tax income growth 1.25-1.5x CRWV's 9.63%. Bruce Berkowitz would examine sustainability.
-6.20%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
3.00%
Similar tax expense growth to CRWV's 3.78%. Walter Schloss would investigate patterns.
15.44%
Net income growth exceeding 1.5x CRWV's 7.67%. David Dodd would verify competitive advantages.
-3.98%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
16.18%
EPS growth 50-75% of CRWV's 23.08%. Martin Whitman would scrutinize operations.
14.71%
Diluted EPS growth 50-75% of CRWV's 23.08%. Martin Whitman would scrutinize operations.
0.12%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
-0.29%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.